A model for the development and implementation of a national plan for the optimal management of early spondyloarthritis: The Esperanza Program

Annals of the Rheumatic Diseases

Volumn 70, Issue 5, 2011, Pages 827-830

  Muñoz Fernández, Santiago ^a   Carmona, Loreto ^b   Collantes, Eduardo ^c,d   Mulero, Juan ^e,f   García Yébenes, M Jesús ^b   De Miguel, Eugenio ^g   Almodovar, Raquel ^h   Fernández Carballido, Cristina ⁱ   Llorente, JoséFrancisco García ^j   Gobbo, Milena ^b  

^a HOSPITAL UNIVERSITARIO INFANTA SOFÍA   (Spain)

^b UNIDAD DE INVESTIGACIÓN   (Spain)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^d UNIVERSITY OF CÓRDOBA   (Spain)

^e HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^f UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^g HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^h HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

ⁱ HOSPITAL GENERAL DE ELDA   (Spain)

^j HOSPITAL DE BASURTO   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PROTOCOL; HEALTH CARE ACCESS; HEALTH PROGRAM; PATIENT REFERRAL; PERFORMANCE; PRIORITY JOURNAL; RELIABILITY; RHEUMATOLOGY; SPONDYLOARTHROPATHY; STANDARDIZATION;

EID: 79953327477     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.141200     Document Type: Article

References (16)

1. Gobbo M, Carmona L, Esperanza Study Group. Motivating factors and barriers to establishing a clinical pathway for the early management of spondyloarthropathies: a qualitative study. Ann Rheum Dis 2008;67 (Suppl II):385.
2. Braun J, Brandt J, Listing J, et al. Treatment of active ankylosing spondylitis with infliximab:a randomised controlled multicentre trial. Lancet 2002;359:1187-93. (Pubitemid 34304258)
3. Gorman JD, Sack KE, Davis JC, Jr. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med 2002;346:1349-56. (Pubitemid 34754607)
4. van der Heijde D, Kivitz A, Schiff MH, et al. Efficacy and safety of adalimumab in patients with ankylosing spondylitis:results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2006;54:2136-46.
5. Goëb V, Smolen J, Emery P, et al. Early inflammatory clinics. Experience with early arthritis/back pain clinics. Clin Exp Rheumatol 2009;27 ( 4 Suppl 55 ):S74-9.
6. Gough A, Young A, Bacon P. Objectives and outcome of running an early inflammatory arthritis clinic. Baillieres Clin Rheumatol 1992;6:261-83.
7. Klareskog L, Nordmark B, Lindblad S. On the organization of an early arthritis clinic. Best Pract Res Clin Rheumatol 2001;15:1-15. (Pubitemid 32396427)
8. Sokka T, Mäkinen H. An excellent example of an early arthritis clinic - what is its clinical value? J Rheumatol 2009;36:1355-6.
9. Institute for Healthcare Improvement. How to Improve, 2010. http://www.ihi.org/IHI/Topics/Improvement/ImprovementMethods/HowToImprove/ (accessed 17 Dec 2009)
10. Langley G, Nolan K, Nolan T, et al. The Improvement Guide:A Practical Approach to Enhancing Organizational Performance. Second edn. San Francisco:Jossey-Bass Publishers, 2009.
11. Muñoz-Fernández S, de Miguel E, Cobo-Ibáñez T, et al. Early spondyloarthritis: results from the pilot registry ESPIDEP. Clin Exp Rheumatol 2010;28:498-503.
12. Carbonell J, Cobo T, Balsa A, et al. The incidence of rheumatoid arthritis in Spain:results from a nationwide primary care registry. Rheumatology (Oxford) 2008;47:1088-92. (Pubitemid 351865940)
13. Alonso Ruiz A, Vidal Fuentes J, Tornero Molina J, et al. Standards of quality care in rheumatology. Reumatol Clin 2007;3:218-25.
14. Collantes E, Zarco P, Muñoz E, et al. Disease pattern of spondyloarthropathies in Spain:description of the first national registry (REGISPONSER) extended report. Rheumatology (Oxford) 2007;46:1309-15. (Pubitemid 47244507)
15. Feldtkeller E, Khan MA, van der Heijde D, et al. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 2003;23:61-6.
16. Descalzo MÁ, Villaverde V, Carmona L, et al. Characteristics of early arthritis units that may be associated with better referral efficiency:survey to SERAP units. Reumatol Clin 2011 (In press).